93
93M1.XETRA MPH Health Care AG
- Market cap
- EUR 123M
- P/E
- 2.5x
- P/B
- 0.49x
- ROE
- 8.1%
- Dividend yield
- 17.36%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 93M1.XETRA undervalued?
Graham numberThe Graham number of MPH Health Care AG cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MPH Health Care AG fundamental analysis
No fundamental analysis for MPH Health Care AG yet.
MPH Health Care AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MPH Health Care AG
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It operates through Beauty, Pharma, and Real Estate segments. The company offers medical-aesthetic beauty surgeries and treatments, as well as operation and provision of medical infrastructures for partner companies; and sells pharmaceuticals and medical products in the areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. It also provides…
Full company profileMPH Health Care AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MPH Health Care AG annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 8.89M | 33.8M | 44.8M | 6.31M | -9.02M | 4.36M | 6.85M | 7.24M | 6.11M | 364M | 444K |
| Gross Profit | 8.87M | 33.8M | 44.1M | 5.97M | -9.45M | 4.01M | 6.80M | 126M | 6.11M | 364M | 331K |
| Operating Income | 7.89M | 33.1M | 43.7M | 11.6M | -71.0M | -9.07M | 29.6M | 30.2M | 33.0M | 34.6M | 21.5M |
| EBITDA | 85.4M | 33.1M | 37.7M | 11.6M | -71.0M | -9.05M | 29.7M | 30.4M | 33.3M | 34.1M | 21.7M |
| Net Income | 80.1M | 31.9M | 37.0M | 11.1M | -70.4M | -8.96M | 29.1M | 29.5M | 32.0M | 29.3M | 20.0M |
| EPS | 19 | 7.44 | 8.65 | 2.59 | -16 | -2.09 | 6.80 | 6.90 | 7.48 | 6.84 | 4.68 |
| Balance Sheet | |||||||||||
| Total Assets | 230M | 257M | 286M | 293M | 211M | 198M | 237M | 266M | 291M | 258M | 267M |
| Total Liabilities | 16.4M | 16.7M | 17.1M | 21.5M | 9.45M | 5.69M | 15.6M | 15.4M | 13.2M | 14.7M | 18.3M |
| Shareholders' Equity | 214M | 241M | 269M | 272M | 201M | 192M | 221M | 251M | 278M | 243M | 248M |
| Cash & Short-term Investments | 10.4M | 8.29M | 1.08M | 2.10M | 4.23M | 4.44M | 3.82M | 5.10M | 1.20M | 1.37M | 2.82M |
| Total Debt | 14.1M | 14.1M | 14.1M | 18.6M | 7.62M | 4.05M | 13.0M | 13.1M | 10.6M | 11.6M | 15.4M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -4.77M | 1.01M | 5.20M | -1.35M | -3.36M | -1.28M | 3.78K | -2.02M | 1.83M | 7.17M | 18.4M |
| Capital Expenditure | 4.00K | 2.00K | 1.00K | 52.5K | 4.38K | 2.27K | 5.62K | 4.70K | 4.15K | 7.86K | 18.4M |
| Free Cash Flow | -4.77M | 1.01M | 5.20M | -1.40M | -3.36M | -1.28M | -170K | -2.02M | 1.83M | 123K | - |
| Ratios | |||||||||||
| ROE | 37.4% | 13.2% | 13.8% | 4.1% | -35.0% | -4.7% | 13.1% | 11.8% | 11.5% | 12.0% | 8.1% |
| ROA | 34.8% | 12.4% | 12.9% | 3.8% | -33.4% | -4.5% | 12.3% | 11.1% | 11.0% | 11.4% | 7.5% |
| Net Profit Margin | 900.6% | 94.2% | 82.6% | 175.5% | - | -205.3% | 425.0% | 408.3% | 524.3% | 8.0% | 4,504.7% |
| Debt to Equity | 0.07x | 0.06x | 0.05x | 0.07x | 0.04x | 0.02x | 0.06x | 0.05x | 0.04x | 0.05x | 0.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
MPH Health Care AG dividends
- Dividend yield
- 17.36%
- Forward dividend
- 5.00 EUR
- Payout ratio
- -
- Ex-dividend date
- Jul 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | EUR 5.14M | 1.20 | 16.0% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | EUR 8.56M | 2.00 | 77.3% |
| 2018 | EUR 8.56M | 2.00 | 23.1% |
| 2017 | EUR 5.14M | 1.20 | 16.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on Sep 22, 2020.
Who owns MPH Health Care AG
- Insiders 60.00%
- Institutions 0.99%
- Public & others 39.02%
- Shares outstanding 4.28M
- Free float 1.71M
MPH Health Care AG company profile
- Company name
- MPH Health Care AG
- Ticker
- 93M1.XETRA
- ISIN
- DE000A289V03
- Exchange
- XETRA Stock Exchange
- Sector
- Financial Services
- Industry
- Pharmaceuticals
- Employees
- 2
- Fiscal year end
- December
- Address
- Grünauer Straße 5, Berlin, Germany, 12557
- Phone
- 49 30 863 214 560
- Website
- mph-ag.de
About MPH Health Care AG
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It operates through Beauty, Pharma, and Real Estate segments. The company offers medical-aesthetic beauty surgeries and treatments, as well as operation and provision of medical infrastructures for partner companies; and sells pharmaceuticals and medical products in the areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. It also provides plastic and aesthetic treatments and surgeries; and operates European mail-order pharmacy. In addition, the company is involved in real estate business; acts as an investment manager; renewable energies; and project development, including new residential construction/owner occupied homes. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. MPH Health Care AG was incorporated in 2008 and is based in Berlin, Germany.
MPH Health Care AG management
1- Mr. Patrick BrenskeCEO & Member of Management Board